Advancing innovation towards breakthrough cancer therapies

Paris, April 9, 2018 – 6:00 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant cancers, today announced that Nicolas Fellmann, CFO of Onxeo, will present and hold one-to-one meetings with investors at the H.C. Wainwright Annual Global Life Sciences Conference. The conference is being held on April 8-10, 2018, at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Onxeo corporate presentation – H.C. Wainwright Annual Global Life Sciences Conference:

Date: April 10, 2018

Time: 11:30-11:55 am CEST

Location: Salon Atlantique-Meridional (2^nd floor); Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco

  UPCOMING FINANCIAL PUBLICATIONS & EVENTS

• Q1 2018 financial information: Friday, May 4, 2018, after market
• Shareholder’s general meeting on the first call: Wednesday, May 16, 2018
• Shareholder’s general meeting on the second call (if the required quorum was not reached at the first AGM): Tuesday, June 19, 2018

180409_PR_Onxeo_HCW18